Imagine announcing on a Tuesday that you are about to become a public company, filing everything, setting the price range, letting the bankers print the thing, and then quietly taking it all back eight days later. That is roughly where Oura landed this week, pulling a plan to sell shares on the Nasdaq that would have valued the smart ring maker at $15bn (£11.3bn), barely days after the announcement. The company blamed uncertainty in the IPO market and, notably, refused to say when it might try again.
The offer would have raised up to $2.2bn at $40 to $44 a share. Chief executive Tom Hale struck a philosophical note after the withdrawal, saying an IPO is just one step in the journey and that Oura has the luxury of choosing its moment. Luxury is the operative word. Few companies this year have been able to say that with a straight face.
Oura is following someone else off the ledge. Holtec International, a nuclear technology firm, postponed its own flotation earlier this month, citing what it called an unusual confluence of developments that has impaired investor confidence. Energy costs climbing, wars that will not settle, trade friction, inflation sticky enough to keep the Federal Reserve from cutting rates. The yield on US 10-year debt hit its highest level since 2007 this week, and when risk-free money pays like that, speculative listings get repriced hard.
Samuel Kerr, who runs global equity capital markets at Mergermarket, gave the epitaph: we are in a very different IPO market to the one we envisaged just a few weeks ago.
The financials made this one hurt, because they were good. Oura earned a pre-tax profit of $23.5m on sales of $907.8m in the year to 30 September 2025, up from $6.2m the year before, and the nine months to June showed $70m pre-tax on $1.2bn. A profitable hardware business with momentum. Founded in Finland in 2013, run out of San Francisco now, selling rings from about $300 upward that watch your heart rate, sleep and temperature through the night.
There is noise around the product too, which some investors would rather price around. The Clarkson Law Firm filed a class action in August alleging false advertising about sleep tracking, with the memorable claim that Oura rings cannot measure sleep because sleep happens in the brain, not on a finger. Oura stands behind its science, a spokesperson said, noting the ring estimates sleep stages from several physiological signals rather than brain waves alone. The company says the lawsuit played no part in the delay.
Watch the rest of the queue with this in mind. A business with $1.2bn in recent sales and real profits still decided the window was shut. Whatever you think the private markets are worth right now, the founders with weaker numbers and fixed deadlines are the ones to feel it first.